Coloplast to acquire Kerecis for up to USD 1.3 billion

Coloplast signed an agreement to acquire Kerecis, a company in the biologics wound care segment, for up to USD 1.3 billion, with an upfront cash payment of USD 1.2 billion. Kerecis develops wound care products based on fish skin.

“We’re excited to join the Coloplast family and have their support in becoming the world leader in tissue regeneration.”biospace.com

• 1 source
• biospace.comColoplast announces agreement to acquire Kerecis and raises long-term growth expectations - BioSpaceGabrielle MassonJan 31, 2024

Summarized from public sources; check the original articles before acting on it.